Plasma levels and molecular forms of proatrial natriuretic peptides in healthy subjects and in patients with congestive heart failure
- Author
- AZIZI, C1 ; MAISTRE, G1 ; KOMAJDA, M2 ; CARAYON, A1 ; KALOTKA, H2 ; ISNARD, R2 ; BARTHELEMY, C1 ; MASSON, F1 ; PHAM, P3 ; POUSSET, F2 ; EURIN, J1 ; LECHAT, P4
[1] CHU Pitié-Salpêtrière, serv. biochimie, 75634 Paris, France
[2] CHU Pitié-Salpêtrière, serv. cardiologie, Paris, France
[3] CEA Saclay, serv. molécules marquées, 91191 Gif/Yvette, France
[4] CHU Pitié-Salpêtrière, serv. pharmacologie, Paris, France - Source
Journal of endocrinology. 1996, Vol 148, Num 1, pp 51-57 ; ref : 29 ref
- CODEN
- JOENAK
- ISSN
- 0022-0795
- Scientific domain
- Endocrinology
- Publisher
- Portland Press, Colchester
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Exploration hormonale Forme moléculaire Homme Insuffisance cardiaque Peptide ANP Prohormone Appareil circulatoire pathologie Cardiopathie Hormone natriurétique
- Keyword (en)
- Hormonal investigation Molecular form Human Heart failure Atrial natriuretic peptide Prohormone Cardiovascular disease Heart disease Natriuretic hormone
- Keyword (es)
- Análisis hormonal Forma molecular Hombre Insuficiencia cardíaca Péptido ANP Prohormona Aparato circulatorio patología Cardiopatía Hormona natriurética
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system / 002B12A Heart / 002B12A01 Heart failure, cardiogenic pulmonary edema, cardiac enlargement
- Discipline
- Cardiology. Circulatory system
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 2963315
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1677/joe.0.1480051 
https://dx.doi.org/10.1677/joe.0.1480051
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1677\/joe.0.1480051\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:133:\"Plasma levels and molecular forms of proatrial natriuretic peptides in healthy subjects and in patients with congestive heart failure\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Journal of endocrinology\";s:9:\"\u0000*\u0000stitle\";s:13:\"J. endocrinol\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:3:\"148\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"51\";s:8:\"\u0000*\u0000epage\";s:2:\"57\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-0795\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"AZIZI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:10:\"MAISTRE, G\";i:1;s:10:\"KOMAJDA, M\";i:2;s:10:\"CARAYON, A\";i:3;s:10:\"KALOTKA, H\";i:4;s:9:\"ISNARD, R\";i:5;s:13:\"BARTHELEMY, C\";i:6;s:9:\"MASSON, F\";i:7;s:7:\"PHAM, P\";i:8;s:10:\"POUSSET, F\";i:9;s:8:\"EURIN, J\";i:10;s:9:\"LECHAT, P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JOENAK\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:133:\"Plasma levels and molecular forms of proatrial natriuretic peptides in healthy subjects and in patients with congestive heart failure\";s:8:\"\u0000*\u0000place\";s:10:\"Colchester\";s:6:\"\u0000*\u0000pub\";s:14:\"Portland Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1677\/joe.0.1480051\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:133:\"Plasma levels and molecular forms of proatrial natriuretic peptides in healthy subjects and in patients with congestive heart failure\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Journal of endocrinology\";s:9:\"\u0000*\u0000stitle\";s:13:\"J. endocrinol\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:3:\"148\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"51\";s:8:\"\u0000*\u0000epage\";s:2:\"57\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-0795\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"AZIZI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:10:\"MAISTRE, G\";i:1;s:10:\"KOMAJDA, M\";i:2;s:10:\"CARAYON, A\";i:3;s:10:\"KALOTKA, H\";i:4;s:9:\"ISNARD, R\";i:5;s:13:\"BARTHELEMY, C\";i:6;s:9:\"MASSON, F\";i:7;s:7:\"PHAM, P\";i:8;s:10:\"POUSSET, F\";i:9;s:8:\"EURIN, J\";i:10;s:9:\"LECHAT, P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JOENAK\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:133:\"Plasma levels and molecular forms of proatrial natriuretic peptides in healthy subjects and in patients with congestive heart failure\";s:8:\"\u0000*\u0000place\";s:10:\"Colchester\";s:6:\"\u0000*\u0000pub\";s:14:\"Portland Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:21:\"10.1677\/joe.0.1480051\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1677\/joe.0.1480051\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:133:\"Plasma levels and molecular forms of proatrial natriuretic peptides in healthy subjects and in patients with congestive heart failure\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Journal of endocrinology\";s:9:\"\u0000*\u0000stitle\";s:13:\"J. endocrinol\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:3:\"148\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"51\";s:8:\"\u0000*\u0000epage\";s:2:\"57\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-0795\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"AZIZI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:10:\"MAISTRE, G\";i:1;s:10:\"KOMAJDA, M\";i:2;s:10:\"CARAYON, A\";i:3;s:10:\"KALOTKA, H\";i:4;s:9:\"ISNARD, R\";i:5;s:13:\"BARTHELEMY, C\";i:6;s:9:\"MASSON, F\";i:7;s:7:\"PHAM, P\";i:8;s:10:\"POUSSET, F\";i:9;s:8:\"EURIN, J\";i:10;s:9:\"LECHAT, P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JOENAK\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:133:\"Plasma levels and molecular forms of proatrial natriuretic peptides in healthy subjects and in patients with congestive heart failure\";s:8:\"\u0000*\u0000place\";s:10:\"Colchester\";s:6:\"\u0000*\u0000pub\";s:14:\"Portland Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1677\/joe.0.1480051\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:133:\"Plasma levels and molecular forms of proatrial natriuretic peptides in healthy subjects and in patients with congestive heart failure\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Journal of endocrinology\";s:9:\"\u0000*\u0000stitle\";s:13:\"J. endocrinol\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:3:\"148\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"51\";s:8:\"\u0000*\u0000epage\";s:2:\"57\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-0795\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"AZIZI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:10:\"MAISTRE, G\";i:1;s:10:\"KOMAJDA, M\";i:2;s:10:\"CARAYON, A\";i:3;s:10:\"KALOTKA, H\";i:4;s:9:\"ISNARD, R\";i:5;s:13:\"BARTHELEMY, C\";i:6;s:9:\"MASSON, F\";i:7;s:7:\"PHAM, P\";i:8;s:10:\"POUSSET, F\";i:9;s:8:\"EURIN, J\";i:10;s:9:\"LECHAT, P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JOENAK\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:133:\"Plasma levels and molecular forms of proatrial natriuretic peptides in healthy subjects and in patients with congestive heart failure\";s:8:\"\u0000*\u0000place\";s:10:\"Colchester\";s:6:\"\u0000*\u0000pub\";s:14:\"Portland Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1677\/joe.0.1480051\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:133:\"Plasma levels and molecular forms of proatrial natriuretic peptides in healthy subjects and in patients with congestive heart failure\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Journal of endocrinology\";s:9:\"\u0000*\u0000stitle\";s:13:\"J. endocrinol\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:3:\"148\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"51\";s:8:\"\u0000*\u0000epage\";s:2:\"57\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-0795\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"AZIZI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:10:\"MAISTRE, G\";i:1;s:10:\"KOMAJDA, M\";i:2;s:10:\"CARAYON, A\";i:3;s:10:\"KALOTKA, H\";i:4;s:9:\"ISNARD, R\";i:5;s:13:\"BARTHELEMY, C\";i:6;s:9:\"MASSON, F\";i:7;s:7:\"PHAM, P\";i:8;s:10:\"POUSSET, F\";i:9;s:8:\"EURIN, J\";i:10;s:9:\"LECHAT, P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JOENAK\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:133:\"Plasma levels and molecular forms of proatrial natriuretic peptides in healthy subjects and in patients with congestive heart failure\";s:8:\"\u0000*\u0000place\";s:10:\"Colchester\";s:6:\"\u0000*\u0000pub\";s:14:\"Portland Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
